MedGenome, backed by Sequoia Capital, acquires Delhi-NCR based Prognosis Laboratories
26 May 2023
MedGenome on Friday acquired Delhi-NCR-based diagnostic lab Prognosis Laboratories. The financial details of the acquisition were not disclosed. The acquisition will help Bengaluru-based MedGenome to accelerate growth and geographic penetration. "The transaction augments MedGemone's comprehensive diagnostic portfolio, a foothold in Northern India, coupled with complementary business models and natural synergies to drive growth and profitability," Medgenome said in a statement.
MedGenome on Friday acquired Delhi-NCR-based diagnostic lab Prognosis Laboratories. The financial details of the acquisition were not disclosed. The acquisition will help Bengaluru-based MedGenome to accelerate growth and geographic penetration. "The transaction augments MedGemone's comprehensive diagnostic portfolio, a foothold in Northern India, coupled with complementary business models and natural synergies to drive growth and profitability," Medgenome said in a statement.
Stay Connected, Stay Informed –
Don’t miss out on exclusive updates, market trends, and real-time investment opportunities. Be the first to know about the latest unlisted stocks, IPO announcements, and curated Fact Sheets, delivered straight to your WhatsApp.
Pre Ipo
Upcoming IPO
Unicorn
Planify Enterprises Private Limited
Planify Capital Limited
Licensed By
Mutual Fund License No.:
ARN-164419
IRDA Code (1):
ABLIC1003123454
IRDA Code (2):
ABLIC1003131639
Startup India Certificate No.:
DIPP93786
Other Websites
ⓒ 2016-2026 Planify. All rights reserved, Built with
in India
